Add to Favorites Newsroom RSS Share
San Diego, CA USA

Our News on Newswise

Turning A Phage

With microbial resistance to antibiotics growing into a major global health crisis, researchers at University of California San Diego School of Medicine, in collaboration with national research institutions and private industry, are leveraging...
21-Jun-2018 10:05 AM EDT Add to Favorites

061518_vitamin_d_capsules_pixabay.jpg

Greater Levels of Vitamin D Associated with Decreasing Risk of Breast Cancer

Researchers at University of California San Diego School of Medicine suggest higher levels of vitamin D are associated with decreasing risk of breast cancer. Their epidemiological study is published in the June 15 online issue of PLOS ONE, in...
15-Jun-2018 2:00 PM EDT Add to Favorites

bangladesh_children_flickr_IRRI.jpg

UC San Diego Launches New Center for Anti-Parasitic Drug Discovery and Development

Neglected tropical diseases are a group of chronic and disabling parasitic infections that primarily affect poor and underserved communities. These diseases affect more than 1 billion people globally, yet are rarely the target of new drug discovery...
13-Jun-2018 1:05 PM EDT Add to Favorites

bode_lars_ejepson.jpg

Composition of Complex Sugars in Breast Milk May Prevent Future Food Allergies

The unique composition of a mother’s breastmilk may help to reduce food sensitization in her infant, report researchers at the University of California San Diego School of Medicine with colleagues in Canada.
12-Jun-2018 11:05 AM EDT Add to Favorites

millen_marlene.jpg

What’s Inside Your Medical Record?

Patients at UC San Diego Health can now read the medical notes signed by their primary care physician. This move toward transparency is part of an international trend to make patients feel more in control of their health care.
6-Jun-2018 3:05 PM EDT Add to Favorites

Witztum_aorta_OxPL.png

Antibody Blocks Inflammation, Protects Mice from Hardened Arteries and Liver Disease

Researchers at University of California San Diego School of Medicine discovered that they can block inflammation in mice with a naturally occurring antibody that binds oxidized phospholipids (OxPL), molecules on cell surfaces that get modified by...
6-Jun-2018 1:05 PM EDT Add to Favorites

Phase I Trial Finds Experimental Drug Safe in Treating Chronic Lymphocytic Leukemia

Reporting results from a first-in-human phase I clinical trial, researchers at University of California San Diego School of Medicine have found that treatment with cirmtuzumab, an experimental monoclonal antibody-based drug, measurably inhibited the...
30-May-2018 1:05 PM EDT Add to Favorites

Stem Cell-Based Phase I Trial to Repair Spinal Cord Injuries Produces Encouraging Results

Researchers at University of California San Diego School of Medicine report that a first-in-human phase I clinical trial in which neural stem cells were transplanted into participants with chronic spinal cord injuries produced measurable improvement...
29-May-2018 1:05 PM EDT Add to Favorites


see all news

Our YouTube Videos





Chat now!